Form 4 for EOG EOG Resources
Accepted 2024-05-14 00:00:00 ET · period of report 2024-05-10 · accession 0001127602-24-015195 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-14 | 2024-05-10 | EOG | Leitzell Jeffrey R. | EVP, COO | S - Sale+OE | $130.07 | -7,802 | 45.7K | -15% | -$1.01M |
| D | 2024-05-14 | 2024-05-10 | EOG | Leitzell Jeffrey R. | EVP, COO | F - Tax | $129.98 | -389 | 46.9K | -0.8% | -$50.6K |
| D | 2024-05-14 | 2024-05-10 | EOG | Leitzell Jeffrey R. | EVP, COO | M - OptEx | $96.29 | +6,150 | 51.8K | +13% | +$592.2K |
| D | 2024-05-14 | 2024-05-10 | EOG | Leitzell Jeffrey R. | EVP, COO | D - Sale to Iss | $129.98 | -4,556 | 47.2K | -9% | -$592.2K |
| D | 2024-05-14 | 2024-05-10 | EOG | Leitzell Jeffrey R. | EVP, COO | M - OptEx | $0.00 | -6,150 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-10 | S | D | 6,597 | $130.09 | 39,053.61 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-10 | S | D | 1,205 | $129.97 | 45,650.61 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-10 | F | D | 389 | $129.98 | 46,855.61 | D | — | — | |
| 4 | Common | Common Stock | 2024-05-10 | M | A | 6,150 | $96.29 | 51,800.61 | D | — | — | |
| 5 | Common | Common Stock | 2024-05-10 | D | D | 4,556 | $129.98 | 47,244.61 | D | — | — | |
| 6 | Derivative | Stock Appreciation Rights | 2024-05-10 | M | D | 6,150 | $0.00 | 0 | D | $96.29 · 2018-09-25 to 2024-09-25 | 6,150 Common Stock | (F1) The SARs granted became exercisable in increments of 33%, 33%, and 34% on each of the first three anniversaries, respectively, of the September 25, 2017 date of grant. The SARs granted became fully exercisable on September 25, 2020. |